Metformin Teva

Metformin Hydrochloride, the active ingredient in Metformin Teva, is a biguanide presented as an oral dosage form for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus. The drug works by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, helping to lower elevated blood sugar levels.

GNH USA supplies Metformin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution to meet the needs of healthcare providers.

Metformin Teva is a biguanide that acts on glucose metabolism in type 2 diabetes and related conditions.

- Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Impaired glucose tolerance: delays progression to overt diabetes. - Polycystic ovary syndrome: improves insulin resistance and may restore ovulatory function.

Metformin Teva may cause a range of adverse reactions, most of which are related to the gastrointestinal tract.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often transient. - Abdominal discomfort: cramping or pain. - Metallic taste: altered taste sensation. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long term.

Serious or Rare Side Effects: - Lactic acidosis: accumulation of lactate leading to metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycemia: especially when combined with insulin or sulfonylureas.

When prescribing Metformin Teva, clinicians should consider several safety precautions to minimize risk.

- Renal function: assess baseline creatinine clearance and monitor periodically. - Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment. - Alcohol consumption: limit intake to reduce lactic acidosis potential. - Pregnancy: evaluate benefits versus risks and consult obstetric guidance. - Drug interactions: review concomitant medications that may affect metformin levels. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Metformin Teva can interact with other medicines, altering its plasma concentration or increasing adverse effect risk.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma levels, heightening toxicity. - Alcohol excess: synergistic effect on lactate accumulation.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - Other antidiabetic agents: combined therapy may increase hypoglycemia risk.